Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting primary and secondary mediation analyses of randomised trials and observational studies. |
| Full bibliographic reference | Lee H, Cashin AG, Lamb SE, Hopewell S, Vansteelandt S, VanderWeele TJ, MacKinnon DP, Mansell G, Collins GS, Golub RM, McAuley JH; AGReMA group, Localio AR, van Amelsvoort L, Guallar E, Rijnhart J, Goldsmith K, Fairchild AJ, Lewis CC, Kamper SJ, Williams CM, Henschke N. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement. JAMA. 2021;326(11):1045-1056. |
| Language | English |
| PubMed ID | 34546296 |
| Relevant URLs (full-text if available) |
Access the AGReMA checklist for reporting mediation analyses of randomised controlled trials and observational studies as a primary objective. Access the AGReMA-SF checklist for reporting secondary mediation analyses within primary reports of randomised controlled trials and observational studies. |
| Reporting guideline website URL | https://agrema-statement.org/ |
| Reporting guideline acronym | AGReMA |
| Study design | Clinical trials, Experimental studies, Observational studies |
| Applies to the whole report or to individual sections of the report? | Statistical methods and analyses |
| Additional information | Read about the development of the AGReMA reporting guideline. |
| Record last updated on | September 23, 2021 |